Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,500,000
Closed -$18.2M 56
2025
Q1
$18.2M Buy
+2,500,000
New +$21.9M 3.23% 11
2023
Q4
Sell
-310,000
Closed -$4.79M 58
2023
Q3
$4.79M Buy
+310,000
New +$5.2M 0.64% 39
2020
Q3
Sell
-290,000
Closed -$5.78M 50
2020
Q2
$5.78M Buy
290,000
+43,000
+17% +$1.05M 1.16% 30
2020
Q1
$6.24M Buy
247,000
+160,409
+185% +$4.69M 2.37% 16
2019
Q4
$2.28M Buy
+86,591
New +$2.41M 0.56% 35

Other funds holding ETNB

Logos Global Management's ETNB Position: Q2 2025 in Review

Logos Global Management sold out of 89bio (ETNB) in Q2 2025, closing a stake of 2,500,000 shares — an estimated $18.2M sold.

Logos Global Management first reported a position in ETNB in Q4 2019 and held it in 5 quarters. The position peaked at $18.2M in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Logos Global Management reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Logos Global Management sold 2,500,000 89bio shares in Q2 2025, an estimated $18.2M.
  • Logos Global Management first reported a position in 89bio in Q4 2019 and held it in 5 quarters.
  • Logos Global Management's 89bio position peaked at $18.2M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Logos Global Management's 13F filing for Q2 2025, filed 14 Aug 2025.